查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1998667

非電動靜脈輸液幫浦市場：商業機會、成長要素、產業趨勢分析及 2026-2035 年預測。

Non-electric Intravenous Infusion Pump Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球非電動靜脈輸液幫浦市場預計到 2025 年價值 6.5 億美元，預計到 2035 年將達到 10 億美元，年複合成長率為 4.7%。

非電動靜脈輸液幫浦市場-IMG1

非電動靜脈輸液幫浦市場的成長主要受全球慢性病盛行率上升和外科手術量增加的推動。此外，醫療專業人員日益尋求經濟實惠的電動輸液設備替代方案，推動了對機械輸液技術的需求。非電動靜脈輸液幫浦是一種緊湊型醫療設備，無需電池或電源即可按控制速率輸注液體和藥物。其設計確保了藥物傳輸的穩定性，同時操作簡單。在傳統醫院環境之外，持續或長期給藥的需求不斷成長，也促進了這個市場需求。這些系統以其便攜性、易操作性和極低的維護需求而著稱，使其成為居家醫療項目和資源有限的醫療機構的理想選擇。此外，它們能夠提高患者的活動能力並促進早期出院，這加速了其在各種臨床環境中的通訊協定。居家醫療的興起進一步推動了非電動輸液技術的應用。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 6.5億美元
預測金額 10億美元
複合年成長率 4.7%

到2025年，彈性體輸液幫浦將佔據85.7%的市場佔有率，這主要得益於其實用設計、便攜性和可靠的藥物輸送能力。彈性體輸液幫浦是目前非電動靜脈輸液幫浦產業中應用最廣泛的類型，因為它們無需複雜的裝置或電子元件即可實現持續藥物傳輸。這些設備依靠彈性儲液器以可控的速率逐步釋放藥物，從而確保治療的穩定性。其緊湊的設計和靜音運行顯著提升了患者和醫護人員的使用便利性，尤其是在移動性和易用性至關重要的醫療環境中。

腫瘤領域將在2025年佔據最大的銷售佔有率，達到35.7%，預計到2035年將達到3.889億美元。這主要得益於需要穩定可控藥物輸送的長期靜脈輸液需求的日益成長。非電動輸液系統因其高度便攜的設計而被廣泛應用於腫瘤治療項目中，使得治療能夠在傳統醫院之外進行。預計在整個預測期內，癌症在全球範圍內日益加重以及分散式腫瘤護理服務的擴展將繼續推動對這些輸液系統的需求。

美國非電動靜脈輸液幫浦市場預計到2025年將達到2.532億美元。這主要得益於醫療手術量的激增、門診輸液治療的日益普及以及完善的居家醫療體系。優惠的報銷政策和對門診模式日益成長的依賴也持續推動此類設備的普及。此外，成熟製造商的存在以及醫療專業人員對彈性體輸液技術的持續深入理解，也促進了醫院、門診機構和家庭醫療保健服務提供者對此類設備的持續需求。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性通訊協定
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 慢性病盛行率增加
      • 接受手術的人數正在增加。
      • 過渡到居家照護
      • 市場對低成本電子幫浦替代品的需求正在激增。
    • 產業潛在風險與挑戰
      • 其在重症臨床環境的應用受到限制。
    • 市場機遇
      • 居家照護和門診靜脈輸液治療服務的成長
  • 成長潛力分析
  • 監理情勢
    • 北美洲
    • 歐洲
    • 亞太地區
  • 技術趨勢（基於初步調查）
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢（基於初步研究）
  • 專利分析
  • 價格分析（基於初步調查）
  • 客戶洞察（基於初步研究）
  • 人工智慧和生成式人工智慧對市場的影響
  • 波特的分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品類型發布
    • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

  • 彈性體輸液泵
  • 機械幫浦

第6章 市場估計與預測：依應用領域分類，2022-2035年

  • 腫瘤學
  • 小兒科/新生兒科
  • 疼痛管理
  • 糖尿病
  • 胃腸病學
  • 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

  • 醫院
  • 門診手術中心
  • 居家照護設施
  • 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • Ambu
  • AVANOS
  • B. Braun
  • Baxter
  • epic
  • Go Medical Industries
  • Multimedical
  • NIPRO
  • Technoline
  • VYGON
簡介目錄
Product Code: 15662

The Global Non-electric Intravenous Infusion Pump Market was valued at USD 650 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 1 billion by 2035.

Non-electric Intravenous Infusion Pump Market - IMG1

Growth across the non-electric intravenous infusion pump market for non-electric systems is supported by the increasing prevalence of long-term medical conditions and the rising number of surgical interventions worldwide. Healthcare providers are also increasingly looking for economical alternatives to electrically powered infusion devices, which is strengthening the demand for mechanical infusion technologies. Non-electric intravenous infusion pumps are compact medical devices designed to administer fluids and medications at controlled rates without the need for batteries or electrical power. Their design allows consistent delivery of therapeutic agents while maintaining operational simplicity. Demand is also rising due to the increasing need for continuous or extended drug administration outside conventional hospital settings. These systems are recognized for their portability, straightforward operation, and minimal maintenance requirements, making them well-suited for home healthcare programs and facilities with limited resources. Additionally, the ability of these pumps to support improved patient mobility and facilitate early discharge protocols has accelerated their acceptance in various clinical environments. The growing shift toward home-centered medical care is further strengthening the adoption of non-electric infusion technologies.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$650 Million
Forecast Value$1 Billion
CAGR4.7%

The elastomeric infusion pumps segment accounted for a substantial 85.7% share in 2025, driven by their practical design, portability, and dependable medication delivery capabilities. Elastomeric infusion pumps represent the most widely utilized category within the non-electric intravenous infusion pump industry because they provide continuous drug administration without requiring complex setup or electronic components. These devices rely on an elastic reservoir that gradually releases medication at a controlled rate, ensuring consistent therapy delivery. Their compact structure and silent functioning enhance convenience for patients and healthcare professionals, particularly in care environments where mobility and ease of use are essential.

The oncology application segment held a leading revenue share of 35.7% in 2025 and is projected to reach USD 388.9 million by 2035, owing to the increasing use of prolonged infusion therapies that require stable and controlled medication delivery. Non-electric infusion systems are widely utilized in oncology treatment programs because their portable design supports therapy administration beyond traditional hospital environments. The increasing global burden of cancer and the expansion of decentralized oncology care services are expected to continue driving demand for these infusion systems throughout the forecast period.

U.S. Non-electric Intravenous Infusion Pump Market generated USD 253.2 million in 2025, supported by high volumes of medical procedures, widespread use of ambulatory infusion therapies, and a well-developed home healthcare ecosystem. Favorable reimbursement frameworks and increasing reliance on outpatient care models continue to strengthen the adoption of these devices. Additionally, the presence of established manufacturers and growing familiarity among healthcare professionals with elastomeric infusion technologies are contributing to sustained demand across hospitals, outpatient facilities, and home-based treatment providers.

Key companies operating in the Global Non-electric Intravenous Infusion Pump Market include Baxter, B. Braun, AVANOS, Ambu, NIPRO, VYGON, Go Medical Industries, Technoline, Multimedical, and Epic. Companies participating in the Non-electric Intravenous Infusion Pump Market are implementing several strategic initiatives to strengthen their market position and expand global reach. Leading manufacturers are focusing heavily on research and development to improve device reliability, safety, and user convenience while maintaining cost efficiency. Many companies are also expanding their product portfolios with advanced infusion systems designed for broader therapeutic applications. Strategic partnerships with healthcare providers and distribution networks are helping organizations increase product accessibility in both developed and emerging healthcare markets. In addition, firms are prioritizing regulatory approvals and compliance with international healthcare standards to accelerate global market entry.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product type trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic conditions
      • 3.2.1.2 Increasing number of people undergoing surgical procedures
      • 3.2.1.3 Shift toward home-based care
      • 3.2.1.4 Surging demand for a low-cost alternative to electronic pumps
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Limited usage in high-acuity clinical settings
    • 3.2.3 Market opportunities
      • 3.2.3.1 Growth of home-care and ambulatory infusion services
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape (Driven by primary research)
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends (Driven by primary research)
  • 3.7 Patent analysis
  • 3.8 Pricing analysis (Driven by primary research)
  • 3.9 Customer insights (Driven by primary research)
  • 3.10 Impact of AI and generative AI on the market
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Elastomeric infusion pumps
  • 5.3 Mechanical pumps

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Oncology
  • 6.3 Pediatrics/Neonatology
  • 6.4 Pain Management
  • 6.5 Diabetes
  • 6.6 Gastroenterology
  • 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Home care settings
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Ambu
  • 9.2 AVANOS
  • 9.3 B. Braun
  • 9.4 Baxter
  • 9.5 epic
  • 9.6 Go Medical Industries
  • 9.7 Multimedical
  • 9.8 NIPRO
  • 9.9 Technoline
  • 9.10 VYGON